The tissue-specific expression of SCN4A most probably explains why Nav1.4 dysfunction only impacts skeletal muscles even if anecdotic reports of cardiac arrhythmia in individuals with dominant SCN4A mutations have been published (Loussouarn et al., 2015). This evidence concerns the gene SCN4A and chronic obstructive pulmonary disease.